Unknown

Dataset Information

0

Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic.


ABSTRACT: An in-house antibody generation campaign identified a diverse, high affinity set of anti-interleukin-11 (IL-11) monoclonal antibodies (mAbs) to enable successful development of novel, custom ultra-sensitive target engagement assays for detection of "free" (unbound to the dosed anti-IL-11 therapeutic mAb) and "total" (free and mAb-IL-11 complexed form) IL-11 in preclinical species and human. Antibody hits from distinct epitope communities were screened on various platforms, including enzyme-linked immunosorbent assay, Meso Scale Discovery, Simoa HD-1 and Simoa Planar Array (SP-X), and used for assay development and sensitivity optimization. The ultra-sensitive SP-X format achieved a lower limit of quantitation of 0.006 pg/mL, enabling the first reported baseline levels of IL-11 in healthy control plasma determined by custom bioanalytical assays. These newly established baseline levels supported mechanistic pharmacokinetic/pharmacodynamic modeling in mouse, cynomolgus monkey, and human for a greater understanding of preclinical study design and in vivo dynamic interaction of soluble IL-11 with an anti-IL-11 antibody therapeutic candidate. Modeling and simulation also helped refine the utility of assays with respect to their potential use as target engagement biomarkers in the clinic.Abbreviations IL-11: Interleukin-11, TE: Target engagement, PK/PD: Pharmacokinetic/pharmacodynamic, mAb: Monoclonal antibody, NHP: Non-human primate, IgG: Immunoglobulin G, Cyno: Cynomolgulus monkey, GFR: Glomerular filtration rate, BQL: Below quantitation levels, DRM: Disease relevant model, kDa: kilodaltons, SPR: Surface plasmon resonance, pSTAT3: phosphorylated STAT3, IL-11R: Interleukin-11 receptor, TPP: Target product protein, LLOQ: Lower limit of quantitation, RLU: Relative light units.

SUBMITTER: Myzithras M 

PROVIDER: S-EPMC9348130 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic.

Myzithras Maria M   Lin Siqi S   Radden Legairre L   Hess Kenny Cynthia C   Cai Zheng Z   MacDonald Angus A   Binetti Ralph R   Marlow Michael M   Fracasso Paul P   Gibson Glenn G   Bartlett Christina C   Hawkins Julie J   Hansel Steven S  

mAbs 20220101 1


An in-house antibody generation campaign identified a diverse, high affinity set of anti-interleukin-11 (IL-11) monoclonal antibodies (mAbs) to enable successful development of novel, custom ultra-sensitive target engagement assays for detection of "free" (unbound to the dosed anti-IL-11 therapeutic mAb) and "total" (free and mAb-IL-11 complexed form) IL-11 in preclinical species and human. Antibody hits from distinct epitope communities were screened on various platforms, including enzyme-linke  ...[more]

Similar Datasets

| S-EPMC11494920 | biostudies-literature
| S-EPMC5417014 | biostudies-literature
| S-EPMC3889526 | biostudies-literature
| S-EPMC9298258 | biostudies-literature
| S-EPMC11652821 | biostudies-literature
| S-EPMC9276831 | biostudies-literature
| S-EPMC7274454 | biostudies-literature
| S-EPMC9289728 | biostudies-literature
| S-EPMC8092884 | biostudies-literature
| S-EPMC9428150 | biostudies-literature